Refractory Plasma Cell Myeloma
Showing NaN - NaN of 7
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Multiple Myeloma-Light Chain Only, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (drug,
Terminated
- Multiple Myeloma-Light Chain Only
- +2 more
- Dexamethasone
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Bendamustine Hydrochloride, Carfilzomib,
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bendamustine Hydrochloride
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 7, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Dexamethasone
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2020
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Carfilzomib, Dexamethasone, Laboratory
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +2 more
-
Fairbanks, Alaska
- +484 more
Apr 3, 2020
Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Carfilzomib, Filanesib,
Completed
- Plasma Cell Leukemia
- +2 more
- Carfilzomib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 12, 2019